ID COLO 206F AC CVCL_1988 SY Colo-206F; COLO-206F; Colo 206F; COLO206F; COLO 206; COLO206; Colorado 206F DR BTO; BTO_0002199 DR CLO; CLO_0002570 DR EFO; EFO_0006554 DR CLDB; cl864 DR ArrayExpress; E-MTAB-2706 DR cancercelllines; CVCL_1988 DR Cell_Model_Passport; SIDM00822 DR ColonAtlas; COLO206F DR Cosmic; 2760082 DR DSMZ; ACC-21 DR DSMZCellDive; ACC-21 DR ECACC; 93052620 DR EGA; EGAS00001000610 DR EGA; EGAS00001002554 DR GEO; GSM206460 DR GEO; GSM274776 DR GEO; GSM513935 DR GEO; GSM514188 DR GEO; GSM784009 DR GEO; GSM1374453 DR LINCS_LDP; LCL-1159 DR PharmacoDB; COLO206F_215_2019 DR Progenetix; CVCL_1988 DR Wikidata; Q54814077 RX PubMed=6277475; RX PubMed=8464898; RX PubMed=10051639; RX PubMed=11668190; RX PubMed=20606684; RX PubMed=23272949; RX PubMed=25485619; RX PubMed=26589293; RX PubMed=28196595; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: AstraZeneca Colorectal cell line (AZCL) panel. CC Part of: MD Anderson Cell Lines Project. CC Population: Caucasian. CC Doubling time: ~2-3 days (DSMZ=ACC-21). CC HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. ST Source(s): DSMZ=ACC-21 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 10,12 ST D16S539: 12,13 ST D18S51: 18 ST D19S433: 13,14 ST D21S11: 30.2,33.2 ST D2S1338: 17,18 ST D3S1358: 16 ST D5S818: 10,13 ST D7S820: 9,10 ST D8S1179: 9,14 ST FGA: 21,23 ST Penta D: 9,11 ST Penta E: 13,15 ST TH01: 8,9 ST TPOX: 11 ST vWA: 15 DI NCIt; C4349; Colon adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_9976 ! COLO 197 OI CVCL_9977 ! COLO 200 OI CVCL_1987 ! COLO 201 OI CVCL_0218 ! COLO 205 SX Male AG 70Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 36 CH CVCL_4V92 ! COLO206F-AR // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=20606684; DOI=10.1038/sj.bjc.6605780; PMCID=PMC2920028; RA Bracht, Karin RA Nicholls, Angela M. RA Liu, Ying RA Bodmer, Walter Fred RT "5-fluorouracil response in a large panel of colorectal cancer cell RT lines is associated with mismatch repair deficiency."; RL Br. J. Cancer 103:340-346(2010). // RX PubMed=11668190; DOI=10.1177/002215540104901105; RA Quentmeier, Hilmar RA Osborn, Mary RA Reinhardt, Julia RA Zaborski, Margarete RA Drexler, Hans Gunther RT "Immunocytochemical analysis of cell lines derived from solid RT tumors."; RL J. Histochem. Cytochem. 49:1369-1378(2001). // RX PubMed=23272949; DOI=10.1186/1755-8794-5-66; PMCID=PMC3543849; RA Schlicker, Andreas RA Beran, Garry RA Chresta, Christine M. RA McWalter, Gael RA Pritchard, Alison RA Weston, Susie RA Runswick, Sarah RA Davenport, Sara RA Heathcote, Kerry RA Castro, Denis Alferez RA Orphanides, George RA French, Tim RA Wessels, Lodewyk F.A. RT "Subtypes of primary colorectal tumors correlate with response to RT targeted treatment in colorectal cell lines."; RL BMC Med. Genomics 5:66.1-66.15(2012). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, Agda Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=8464898; DOI=10.1073/pnas.90.7.2842; PMCID=PMC46192; RA Browning, Michael J. RA Krausa, Peter RA Rowan, Andrew J. RA Bicknell, David C. RA Bodmer, Julia Gwynaeth RA Bodmer, Walter Fred RT "Tissue typing the HLA-A locus from genomic DNA by sequence-specific RT PCR: comparison of HLA genotype and surface expression on colorectal RT tumor cell lines."; RL Proc. Natl. Acad. Sci. U.S.A. 90:2842-2845(1993). // RX PubMed=6277475; RA Frampton, Richard J. RA Suva, Larry J. RA Eisman, John Allan RA Findlay, David M. RA Moore, George Eugene RA Moseley, Jane M. RA Martin, Thomas John RT "Presence of 1,25-dihydroxyvitamin D3 receptors in established human RT cancer cell lines in culture."; RL Cancer Res. 42:1116-1119(1982). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=10051639; DOI=10.1073/pnas.96.5.2316; PMCID=PMC26781; RA Efstathiou, Jason Alexander RA Liu, Dan RA Wheeler, James M.D. RA Kim, Hee C. RA Beck, Nicholas E. RA Ilyas, Mohammad RA Karayiannakis, Anastasios J. RA Mortensen, Neil James RA Kmiot, Witold Andrzej Wladyslaw RA Playford, Raymond John RA Pignatelli, Massimo RA Bodmer, Walter Fred RT "Mutated epithelial cadherin is associated with increased RT tumorigenicity and loss of adhesion and of responsiveness to the RT motogenic trefoil factor 2 in colon carcinoma cells."; RL Proc. Natl. Acad. Sci. U.S.A. 96:2316-2321(1999). //